Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

CDC-Authored Genomics and Precision Health Publications Database|Home|PHGKB

CDC-Authored Genomics and Precision Health Publications Database


Last data update: Mar 29, 2023. (Total: 4251 publications since 2011)
   dataset
Filtered By:
Records 1-4 (of 4 Records)
Query Trace: all>>Melisa Willby[CDC Author]
Molecular evaluation of fluoroquinolone resistance in serial Mycobacterium tuberculosis isolates from individuals diagnosed with multidrug-resistant tuberculosis.
Melisa Willby, Paige Chopra, Darrin Lemmer, Katherine Klein, Tracy L Dalton, David M Engelthaler, Peter Cegielski, James E Posey, and
Antimicrobial agents and chemotherapy 2020 Oct
Rv3351c, a Mycobacterium tuberculosis gene that affects bacterial growth and alveolar epithelial cell viability.
Rebecca L Pavlicek, Kari Fine-Coulson, Tuhina Gupta, Frederick D Quinn, James E Posey, Melisa Willby, Jorge Castro-Garza, and Russell K Karls
Canadian journal of microbiology 2015 Oct 1-10
Mycobacterium tuberculosis pncA polymorphisms that do not confer pyrazinamide resistance at a breakpoint concentration of 100 µg/ml in MGIT.
Michael G Whitfield, Robin M Warren, Elizabeth M Streicher, Samantha L Sampson, Frik A Sirgel, Paul D van Helden, Alexandra Mercante, Melisa Willby, Kelsey Hughes, Kris Birkness, Glenn Morlock, Annelies van Rie, and James E Posey
J. Clin. Microbiol. 2015 Aug 19.
New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations.
Seidu Malik, Melisa Willby, David Sikes, Oleg V Tsodikov, and James E Posey
PLoS ONE 2012 7(6) e39754
TOP